Affiliation: Memorial Sloan-Kettering Cancer Center
- Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?Carla Casulo
Memorial Sloan Kettering Cancer Center, New York, NY 10165, USA
Curr Oncol Rep 12:374-82. 2010..This article seeks to review the literature on the role of ASCT in PTCL, as well as to clarify what may be the optimal disease state in which to offer patients with PTCL autologous transplantation, if at all...